Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 39, Issue 1, January 2014, Pages 5-100
 
LETTER FROM THE EDITOR
 
  
 Drugs Fut 2014, 39(1): 5
Full Text: PDF 
 
  
 
MONOGRAPHS
 
  
 Dasabuvir.
RNA-directed RNA polymerase (NS5B) inhibitor, Treatment of hepatitis C virus infection.
Reviriego, C.
Drugs Fut 2014, 39(1): 7
Full Text: PDF 
 
  
  
 Nivolumab.
Anti-PD-1 monoclonal antibody, Cancer immunotherapy.
Moreira da Silva, R.
Drugs Fut 2014, 39(1): 15
Summary | Full Text: PDF 
 
  
  
 Plazomicin.
Aminoglycoside antibiotic.
Galani, I.
Drugs Fut 2014, 39(1): 25
Summary | Full Text: PDF 
 
  
 
REVIEW ARTICLE
 
  
 Spotlight on melanoma – A Pharma Matters report.
Al-Shamahi, A., Ogbighele, M.
Drugs Fut 2014, 39(1): 37
Summary | Full Text: PDF 
 
  
 
DRUGLINE
 
  
 Pipeline on the move.
Drugs Fut 2014, 39(1): 49
Full Text: PDF 
 
  
  
 NME digest.
Drugs Fut 2014, 39(1): 57
Full Text: PDF 
 
  
 
MEETING REPORTS
 
  
 American Heart Association (AHA) Scientific Sessions 2013, Dallas, Texas, USA – November 16-20, 2013.
Pina,P.
Drugs Fut 2014, 39(1): 81
Summary | Full Text: PDF 
 
  
  
 62nd Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH),Washington, D.C., USA – November 13-17, 2013.
Ghosh,S.
Drugs Fut 2014, 39(1): 85
Summary | Full Text: PDF 
 
  
  
 Orphan Drugs & Rare Diseases – SMI's Second Annual Conference, London, UK – October 14-15, 2013.
Savva, M.
Drugs Fut 2014, 39(1): 91
Summary | Full Text: PDF 
 
  
  
 World Stem Cell Summit 2013, San Diego, California, USA – December 4-6, 2013.
Vertes, A.
Drugs Fut 2014, 39(1): 95
Summary | Full Text: PDF 
 
  
 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy